TD Cowen Increases Clorox (NYSE:CLX) Price Target to $111.00

Clorox (NYSE:CLX) had its target price upped by research analysts at TD Cowen from $108.00 to $111.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. The brokerage currently has a “hold” rating on the stock. TD Cowen’s price objective points to a potential downside of 5.61% from the stock’s previous close.

A number of other equities analysts have also commented on CLX. Jefferies Financial Group decreased their price target on shares of Clorox from $152.00 to $151.00 and set a “buy” rating on the stock in a research note on Wednesday. Wells Fargo & Company lifted their price objective on shares of Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a research note on Friday, January 23rd. Rothschild & Co Redburn reduced their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $114.00 to $112.00 and set a “hold” rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a Buy rating, ten have given a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus price target of $117.93.

Clorox Trading Down 0.1%

NYSE CLX opened at $117.59 on Wednesday. The stock has a 50-day moving average of $105.58 and a 200-day moving average of $114.01. Clorox has a 1-year low of $96.66 and a 1-year high of $159.04. The company has a current ratio of 0.74, a quick ratio of 0.50 and a debt-to-equity ratio of 71.03. The firm has a market cap of $14.22 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 0.57 and a beta of 0.59.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the company posted $1.55 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, sell-side analysts forecast that Clorox will post 7.15 EPS for the current year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction on Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in Clorox by 1.7% in the second quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after acquiring an additional 272,420 shares during the last quarter. State Street Corp increased its holdings in Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Clorox by 23.1% in the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after buying an additional 750,415 shares during the period. Van ECK Associates Corp lifted its position in shares of Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Finally, Two Sigma Investments LP boosted its position in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.